ACS OMEGA, cilt.1, sa.1, ss.1-2, 2022 (SCI-Expanded)
In this study, some new compounds, which are 2-aminothiadiazole derivatives linked by a phenyl bridge to the 2-position of the benzimidazole ring, were designed and synthesizedas antimicrobial agents. The structures of the compounds wereelucidated by 1H and 13C NMR spectroscopy, high-resolution massspectrometry, and elemental analysis. The antifungal activities ofthe synthesized compounds were tested on Candida albicans,Candida krusei, Candida glabrata, and Candida parapsilosis.Compound 5f is more active against C. albicans and C. glabratathan standard fluconazole and varicanazole. Compounds were alsoevaluated for their counteracting activity against Gram-positiveEscherichia coli, Serratia marcescens, Klebsiella pneumoniae, andPseudomonas aeruginosa and Gram-negative Enterococcus faecalis, Bacillus subtilis, and Staphylococcus aureus. Compounds 5c and 5hhad minimum inhibitory concentrations against E. faecalis close to that of the standard azithromycin. Molecular docking studies wereperformed against Candida species’ 14-α demethylase enzyme. 5f was the most active compound against Candida species, which gavethe highest docking interaction energy. The stabilities of compounds 5c and 5f with CYP51 were tested using 100 ns moleculardynamics simulations. According to the theoretical ADME calculations, the profiles of the compounds are suitable in terms oflimiting rules. HOMO−LUMO analysis showed that 5h is chemically more reactive (represented with the lower ΔE = 3.432 eV)than the other molecules, which is compatible with the highest antibacterial activity result.
In this
study, some new compounds, which are 2aminothiadiazole derivatives linked by a
phenyl bridge to the 2 position of the benzimidazole ring, were designed and
synthesized as antimicrobial agents. The structures of the compounds were elucidated
by 1H and 13 C NMR spectroscopy, high-resolution mass spectrometry, and
elemental analysis. The antifungal activities of the synthesized compounds were
tested on Candida albicans, Candida
krusei, Candida glabrata, and Candida
parapsilosis. Compound 5f is more active against C. albicans and C. Glabrata than
standard fluconazole and varicanazole. Compounds were also evaluated for their
counteracting activity against Gram-positive Escherichia coli, Serratia
marcescens, Klebsiella pneumoniae, and Pseudomonas
aeruginosa and Gram-negative Enterococcus faecalis, Bacillus
subtilis, and Staphylococcus aureus. Compounds 5c and 5h had minimum
inhibitory concentrations against E. faecalis close to
that of the standard azithromycin. Molecular docking studies were performed
against Candida species’ 14-α demethylase enzyme.
5f
was the most active compound against Candida species,
which gave the highest docking interaction energy. The stabilities of compounds
5c
and 5f with CYP51 were tested using 100 ns molecular dynamics
simulations. According to the theoretical ADME calculations, the profiles of
the compounds are suitable in terms of limiting rules. HOMO-LUMO analysis
showed that 5h is chemically more reactive (represented with the lower ΔE = 3.432 eV) than the other molecules, which is compatible with the
highest antibacterial activity result.